Physician profile
Erin Cho
NPI 1366825770
$675.21
in general payments reported to CMS, 2019-2025
8 companies · $30.31 in 2025
The $30.31 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.00 · 2020: $86.67 · 2021: $11.63 · 2022: $42.33 · 2023: $323 · 2024: $170 · 2025: $30.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Consulting Fee: $75.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.75 |
| Consulting Fee | $75.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $369.62 | 2019-2025 | Invisalign, Itero Element 5d Plus Lite |
| Straumann USA LLC | $83.38 | 2023 | |
| Hu-Friedy Mfg. Co., LLC | $60.00 | 2020 | |
| Galderma Laboratories, L.P. | $42.33 | 2022 | |
| Patterson Companies, INC. | $39.05 | 2024 | |
| Nobel Biocare USA | $29.44 | 2023 | Nobelactive |
| Pacira Pharmaceuticals Incorporated | $26.14 | 2024 | Exparel |
| Philips North America LLC | $25.25 | 2021-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.